It has also been shown that increased levels of PGDH synthesis, as well as the other serine biosynthetic enzymes, correlates with patient survival outcome and may be used as a prognostic factor for some cancers (Antonov et al., 2014). The gene discussed is PHGDH; the disease is cancer.